<DOC>
	<DOCNO>NCT03018743</DOCNO>
	<brief_summary>Premature ejaculation ( PE ) know one common male sexual dysfunction . Until dapoxetine approve medical treatment option second line therapy case no-response refuse dapoxetine , comprehensive evaluation factor lead dropout need especially real-practice setting . With background , investigator go assesse discontinuation rate dapoxetine treatment patient PE reason discontinuation clinical set throughout follow-up period 2 year .</brief_summary>
	<brief_title>Discontinuation Dapoxetine Treatment Patients With Premature Ejaculation</brief_title>
	<detailed_description>Premature ejaculation ( PE ) know one common male sexual dysfunction . PE deteriorate sexual satisfaction quality life patient partner . Recently , International Society Sexual Medicine ( ISSM ) give definition PE 'male sexual dysfunction characterize ejaculation always nearly always occur prior within 1 min vaginal penetration first sexual experience ( lifelong PE ) , clinically significant reduction latency time , often 3 min less ( acquire PE ) ' . Until , several treatment modality PE introduce . Psychological/behavioral ; pharmacologic therapy , include selective serotonin reuptake inhibitor ( SSRIs ) , tricyclic antidepressant , tramadol , phosphodiesterase 5 inhibitor , alpha 1-andreoreceptor antagonist ; topical anaesthetic , even surgical treatment use PE practice . Dapoxetine first oral pharmacological agent develop treatment PE SSRI approve 60 country PE . The introduction dapoxetine accompany high expectation optimal efficacy/ safety profile show phase 3 trial . However , several clinical study use depoxetine confirm efficacy increase IELT , reveal significant dropout rate likely show treatment use off-label SSRIs . Despite high efficacy safety , discontinuation rate dapoxetine high compare PDE5 inhibitor patient erectile dysfunction ( ED ) . Until dapoxetine approve medical treatment option second line therapy case no-response refuse dapoxetine , comprehensive evaluation factor lead dropout need especially real-practice setting . With background , investigator assesse discontinuation rate dapoxetine treatment patient PE reason discontinuation clinical set throughout follow-up period 2 year .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Premature Ejaculation</mesh_term>
	<criteria>men without history dapoxetine treatment ; &gt; 19 year old ; involvement stable , monogamous relationship female sexual partner penile anatomical deformity ; spinal cord injury ; radical prostatectomy ; pelvic organ surgery ; diagnosis another sexual disorder except ED ; uncontrolled psychiatric disorder ; history major hematological , renal , hepatic abnormality ; history alcoholism substance abuse ; organic illness cause limitation assume SSRIs</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>